Loading....
OUR SPEAKER
Michael Keng, M.D. is an Assistant Professor and holds a clinical faculty appointment in Medicine in the Division of Hematology/Oncology at UVA Cancer Center. He practices at the Emily Couric Clinical Cancer Center in Charlottesville and serves as an inpatient hematologist at UVA Hospital. His clinical areas of interest are: myelodysplastic syndromes, myeloproliferative disorders, acute myeloid leukemia, chronic myeloid leukemia, acute lymphoid leukemia, and aplastic anemia.
WEBINAR DESCRIPTION
Dr. Keng will provide a overview of the current treatment strategies for high risk MDS (myelodysplastic syndromes) patients.
Participants are invited to submit their questions via the webinar platform during the session.
AAMDSIF would like to thank the patients, families, caregivers, friends, foundations,
and corporations whose generous contributions help fund our educational programs.
Thank you for registering for High Risk MDS Treatment Strategies on Thursday, June 4, 2020 at 2pm EDT.
You will receive an email with a registration confirmation
including the webinar link and a call-in phone # for those
participating via telephone. If you do not receive the link,
please check your Spam/Junk folders.
If you have not received a registration confirmation,
please email clark@aamds.org or call (800) 747-2820 x2 no later than 30 minutes
before the webinar is scheduled to begin.
If you are not able to join the webinar, an archived video will be available in 2 - 3 business days on the AAMDSIF website.